GYRE Competitors & Alternatives
Compare Gyre Therapeutics Inc. with similar stocks in the same industry
Biotechnology
GYRE
Main Stock$6.06
Tradestie Score
45
Market Cap
$688.47M
Revenue Growth
0.0%
Analyst Upside
+208.0%
Top Competitors
230 stocks in Biotechnology| Company | Price | Market Cap | P/E | Score | Action |
|---|---|---|---|---|---|
|
TYRA
Tyra Biosciences, Inc. Common Stock
|
$32.17
|
$715.25M | - | 46 | Compare |
|
DAWN
Day One Biopharmaceuticals, Inc. Common Stock
|
$21.53
|
$704.73M | - | 59 | Compare |
|
PVLA
Palvella Therapeutics, Inc. Common Stock
|
$140.87
|
$699.30M | - | 51 | Compare |
|
TERN
Terns Pharmaceuticals, Inc. Common Stock
|
$52.95
|
$683.46M | - | 57 | Compare |
|
ARVN
Arvinas, Inc
|
$8.00
|
$670.30M | - | 54 | Compare |
|
MGTX
MeiraGTx Holdings plc Ordinary Shares
|
$11.93
|
$665.30M | - | 58 | Compare |
|
MPLT
MPLT
|
$12.43
|
$636.20M | - | 51 | Compare |
|
ERAS
Erasca, Inc. Common Stock
|
$17.84
|
$626.91M | - | 51 | Compare |
|
SVRA
Savara Inc.
|
$5.38
|
$611.84M | - | 58 | Compare |
|
KALV
KalVista Pharmaceuticals, Inc. Common Stock
|
$27.00
|
$608.81M | - | 57 | Compare |
More GYRE Analysis
Data updated: Aug 03, 2026 | Industry: Biotechnology (SIC 2834)
230 stocks in this industry